Our research delves into the intricate connection between environmental exposures, genetic predisposition, and the intestinal microbiome that underlies disease progression.  Specifically, we have scrutinized the genetic and dietary facets influencing IBD development and treatment within the burgeoning Hispanic/LatinX community. Presently, the Damas lab spearheads clinical dietary trials aimed at unraveling the therapeutic potential of diet in mitigating IBD. Join us in advancing the frontier in knowledge and therapeutic breakthroughs in the real of inflammatory bowel diseases.